Conversation with The Cancer Letter

NYU’s Art Caplan: Texas ruling that nixes USPSTF authority embodies “bigotry, hatred, and ignorance”

A ruling by a Texas District Court judge that invalidates the Affordable Care Act’s preventive services mandate is based in part on claims that availability of pre-exposure prophylaxis pills would "encourage homosexual behavior and intravenous drug use.”

March 31, 2023

Vol.49 No.13

By Matthew Bin Han Ong

Conversation with The Cancer Letter Regulatory News

FDA’s Fashoyin-Aje: Draft guidance on accelerated approval urges reliance on randomized controlled trials

FDA last week issued a draft guidance that urges sponsors to conduct randomized controlled trials when they seek accelerated approval.

March 31, 2023

Vol.49 No.13

By Jacquelyn Cobb

Cancer History Project Conversation with The Cancer Letter Free

Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization

Soon after real estate developer and investor Jed Manocherian started a non-profit that lobbies for biomedical research, he heard about the outsized role Mary Lasker played in shaping government-funded biomedical research in the U.S.

March 24, 2023

Vol.49 No.12

By Paul Goldberg

Cancer History Project Conversation with The Cancer Letter Free

Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story”

Mary Lasker left a collection of detailed oral histories and a massive archive of documents, kept at Columbia University: 795 boxes and 7 flat boxes, which amount to 353 linear feet.

March 24, 2023

Vol.49 No.12

By Paul Goldberg

Conversation with The Cancer Letter

UNM’s Sanchez: To provide cancer care to Native American, Hispanic communities, you must first establish trust

No Hispanic woman has ever served as director of an NCI-designated cancer center. This changed a month ago, on Feb. 6, when Yolanda Sanchez became director and CEO of The University of New Mexico Comprehensive Cancer Center.

March 10, 2023

Vol.49 No.10

By Paul Goldberg

Conversation with The Cancer Letter Free

Ukraine’s year of war has produced a generation of women oncologists trained in the West

Over the past year, dozens of Ukraine’s female oncologists, who—unlike draft-age men—aren’t restricted from leaving the country, have been receiving training in Western countries, including the United States.

February 24, 2023

Vol.49 No.08

By Darya Kizub

Conversation with The Cancer Letter Free

Otis Brawley & Robert Winn discuss the killing of Tyre Nichols and the power dynamics in policing—and health care

On May 25, 2020, George Floyd said “I can’t breathe” more than 20 times before he suffocated on a street in Minneapolis. On Jan. 7, 2023, Tyre Nichols repeatedly screamed, “Mom, mom, mom” as he was beaten to death on a street in Memphis.

February 03, 2023

Vol.49 No.05

By Matthew Bin Han Ong

Black History Month Conversation with The Cancer Letter Free

Richard Silvera is bridging advocacy and research through the Robert A. Winn Diversity in Clinical Trials Award Program

Richard Silvera is working to build trust between doctors Bronx communities that have a heavy burden of anal cancer.

February 03, 2023

Vol.49 No.05

By Robert A. Winn

Conversation with The Cancer Letter

Baylor’s Waterland & Coarfa: We see CoRSIVs as the new standard in epigenetic epidemiology

It took a team of researchers more than 18 months to get their paper on epigenetic variation published—likely because they are saying that epigeneticists have been fishing in the wrong pond for a decade.

January 27, 2023

Vol.49 No.04

By Jacquelyn Cobb and Matthew Bin Han Ong

Cancer History Project Conversation with The Cancer Letter

Jim Allison believed in the power of T cells—when hardly anyone else did

Throughout Jim Allison’s early career, the field of oncology appeared to be unfazed by his T cell research. Allison’s introduction to the now-famed immune cell came in an undergraduate immunology course, where even the professor was apprehensive about Allison’s fascination with the recently discovered T cells. “I remember going to see the professor after class […]

January 27, 2023

Vol.49 No.04

By Alexandria Carolan

Conversation with The Cancer Letter

NYU’s Art Caplan: Texas ruling that nixes USPSTF authority embodies “bigotry, hatred, and ignorance”

FDA’s Fashoyin-Aje: Draft guidance on accelerated approval urges reliance on randomized controlled trials

Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization

Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story”

UNM’s Sanchez: To provide cancer care to Native American, Hispanic communities, you must first establish trust

Ukraine’s year of war has produced a generation of women oncologists trained in the West

Otis Brawley & Robert Winn discuss the killing of Tyre Nichols and the power dynamics in policing—and health care

Richard Silvera is bridging advocacy and research through the Robert A. Winn Diversity in Clinical Trials Award Program

Baylor’s Waterland & Coarfa: We see CoRSIVs as the new standard in epigenetic epidemiology

Jim Allison believed in the power of T cells—when hardly anyone else did

Renew today!

Subscriber content